• Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

  • Oct 17 2024
  • Length: 3 mins
  • Podcast

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Listen for free

View show details

  • Summary

  • Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

    Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

    See omnystudio.com/listener for privacy information.
    Show More Show Less
Economics Personal Finance
Show More Show Less
activate_samplebutton_t1

What listeners say about Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.